Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

New Options for Patients with Concurrent Dry Eye & Rheumatic Disease

  |  Issue: May 2019  |  

Vanessa Caceres is a medical writer in Bradenton, Fla.

ADVERTISEMENT
SCROLL TO CONTINUE

Funding Notes

The TFOS DEWS II was supported by unrestricted donations from Alcon, Novartis, Shire, Allergan, Bausch+Lomb, Akorn, CooperVision, Dompé, Horus Pharma, Lμbris BioPharma, Oculeve, TearLab, Laboratoires Théa, SIFI, Sun Pharma, Johnson & Johnson Vision Care, Carl Zeiss Meditec, Quint Health, Scope Ophthalmics and Senju.

References

  1. Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS II Report. Ocular Surface Journal. 2017 Jul.
  2. Asbell PA, Maguire MG, Pistilli M. N-3 fatty acid supplementation for the treatment of dry eye. N Engl J Med. 2018 May 3;378(18):1681–1690.

Related Articles

    How to Improve Oral & Eye Health in Sjögren’s Patients

    ACR CONVERGENCE 2020—Sjögren’s syndrome requires care from several specialists, and presenters at the Sjögren’s Syndrome: Dental and Ocular Perspectives session shared diagnostic and treatment pearls from their respective specialties.  Rebecca Manno, MD, MHS, of the Comprehensive Arthritis and Rheumatology Center of the U.S. Virgin Islands moderated the session.  ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEOral Health Dry…

    Autologous Serum Tears Receives High Patient Satisfaction Scores for Dry Eye Disease

    Although not a first-line treatment, autologous serum tears are often used as a treatment option for dry eyes related to both ophthalmic and rheumatic conditions. Recent research into its efficacy also evaluated the treatment’s patient satisfaction, finding autologous serum tears reduced symptoms of dry eye disease and received high patient satisfaction scores…

    Sjögrens Syndrome: The Need to Bridge Patient Symptoms & Objective Findings

    Sjögrens Syndrome: The Need to Bridge Patient Symptoms & Objective Findings

    Despite a generation of advances in molecular biology, a huge gap exists between the Sjögren’s syndrome (SS) patient’s description of their symptoms and the objective findings. Current issues include: Many SS patients are misclassified as either rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE), even within rheumatology clinics. Frequently, the sickest SS patients with extraglandular…